TP53 and ovarian neoplasm: We used immortalized human FTSE cells (FT318) with a range of TP53 hotspot mutations (R175H, R273H, R273C, R248W, Y220C) that are associated with a GOF phenotype in ovarian tumors (Fig. 4B).